Raras
Buscar doenças, sintomas, genes...
Tumor tireoidiano raro
ORPHA:100087DOENÇA RARA

Um crescimento anormal de tecido que pode ser benigno (não-canceroso) ou maligno (canceroso) na glândula tireoide.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Um crescimento anormal de tecido que pode ser benigno (não-canceroso) ou maligno (canceroso) na glândula tireoide.

Publicações científicas
24 artigos
Último publicado: 2025 Jul-Sep

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
3.2
Worldwide
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

📏
Crescimento
16 sintomas
🦴
Ossos e articulações
11 sintomas
🫘
Rins
10 sintomas
🫃
Digestivo
9 sintomas
🧠
Neurológico
8 sintomas
🫁
Pulmão
7 sintomas

+ 38 sintomas em outras categorias

Características mais comuns

Neoplasia do sistema esquelético
Morfologia anormal do parênquima hepático
Oncocytoma renal
Anormalidade dos linfonodos
Dor óssea
Compressão da medula espinhal
115sintomas
Sem dados (115)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 115 características clínicas mais associadas, ordenadas por frequência.

Neoplasia do sistema esqueléticoNeoplasm of the skeletal system
Morfologia anormal do parênquima hepáticoAbnormal liver parenchyma morphology
Oncocytoma renalRenal oncocytoma
Anormalidade dos linfonodosAbnormality of the lymph nodes
Dor ósseaBone pain

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2025
Total histórico24PubMed
Últimos 10 anos15publicações
Pico20254 papers
Linha do tempo
2025Hoje · 2026🧪 2010Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

33 genes identificados com associação a esta condição.

HRASGTPase HRasDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in the activation of Ras protein signal transduction (PubMed:22821884). Ras proteins bind GDP/GTP and possess intrinsic GTPase activity (PubMed:12740440, PubMed:14500341, PubMed:9020151)

LOCALIZAÇÃO

Cell membraneGolgi apparatusGolgi apparatus membraneNucleusCytoplasmCytoplasm, perinuclear region

VIAS BIOLÓGICAS (2)
Signaling by moderate kinase activity BRAF mutantsEPHB-mediated forward signaling
MECANISMO DE DOENÇA

Costello syndrome

A rare condition characterized by prenatally increased growth, postnatal growth deficiency, intellectual disability, distinctive facial appearance, cardiovascular abnormalities (typically pulmonic stenosis, hypertrophic cardiomyopathy and/or atrial tachycardia), tumor predisposition, skin and musculoskeletal abnormalities.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Not Sun Exposed Suprapubic
107.7 TPM
Skin Sun Exposed Lower leg
104.9 TPM
Esôfago - Mucosa
81.3 TPM
Cérebro - Hemisfério cerebelar
77.6 TPM
Brain Caudate basal ganglia
77.6 TPM
OUTRAS DOENÇAS (10)
nevus, epidermalthyroid cancer, nonmedullary, 2Costello syndromelinear nevus sebaceous syndrome
HGNC:5173UniProt:P01112
SRGAP1SLIT-ROBO Rho GTPase-activating protein 1Candidate gene tested inAltamente restrito
FUNÇÃO

GTPase-activating protein for RhoA and Cdc42 small GTPases. Together with CDC42 seems to be involved in the pathway mediating the repulsive signaling of Robo and Slit proteins in neuronal migration. SLIT2, probably through interaction with ROBO1, increases the interaction of SRGAP1 with ROBO1 and inactivates CDC42

LOCALIZAÇÃO

VIAS BIOLÓGICAS (4)
Inactivation of CDC42 and RAC1RAC1 GTPase cycleCDC42 GTPase cycleRHOA GTPase cycle
MECANISMO DE DOENÇA

Thyroid cancer, non-medullary, 2

A form of non-medullary thyroid cancer (NMTC), a cancer characterized by tumors originating from the thyroid follicular cells. NMTCs represent approximately 95% of all cases of thyroid cancer and are classified into papillary, follicular, Hurthle cell, and anaplastic neoplasms.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
11.4 TPM
Cervix Ectocervix
4.8 TPM
Nervo tibial
4.6 TPM
Pulmão
4.2 TPM
Cervix Endocervix
4.0 TPM
OUTRAS DOENÇAS (1)
thyroid cancer, nonmedullary, 2
HGNC:HGNC:17382UniProt:Q7Z6B7
BRAFSerine/threonine-protein kinase B-rafCandidate gene tested inAltamente restrito
FUNÇÃO

Protein kinase involved in the transduction of mitogenic signals from the cell membrane to the nucleus (Probable). Phosphorylates MAP2K1, and thereby activates the MAP kinase signal transduction pathway (PubMed:21441910, PubMed:29433126). Phosphorylates PFKFB2 (PubMed:36402789). May play a role in the postsynaptic responses of hippocampal neurons (PubMed:1508179)

LOCALIZAÇÃO

NucleusCytoplasmCell membrane

VIAS BIOLÓGICAS (4)
Spry regulation of FGF signalingParadoxical activation of RAF signaling by kinase inactive BRAFARMS-mediated activationSignalling to p38 via RIT and RIN
OUTRAS DOENÇAS (18)
Noonan syndrome 7LEOPARD syndrome 3melanoma, cutaneous malignant, susceptibility to, 1lung cancer
HGNC:1097UniProt:P15056
NCOA4Nuclear receptor coactivator 4Candidate gene tested inTolerante
FUNÇÃO

Cargo receptor for the autophagic turnover of the iron-binding ferritin complex, playing a central role in iron homeostasis (PubMed:25327288, PubMed:26436293). Acts as an adapter for delivery of ferritin to lysosomes and autophagic degradation of ferritin, a process named ferritinophagy (PubMed:25327288, PubMed:26436293). Targets the iron-binding ferritin complex to autolysosomes following starvation or iron depletion (PubMed:25327288). Ensures efficient erythropoiesis, possibly by regulating he

LOCALIZAÇÃO

Cytoplasmic vesicle, autophagosomeAutolysosomeNucleusChromosome

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
122.0 TPM
Fibroblastos
117.3 TPM
Artéria tibial
110.7 TPM
Bladder
108.6 TPM
Esôfago - Muscular
102.7 TPM
OUTRAS DOENÇAS (1)
differentiated thyroid carcinoma
HGNC:7671UniProt:Q13772
PPARGPeroxisome proliferator-activated receptor gammaCandidate gene tested inModerado
FUNÇÃO

Ligand-activated transcription factor that forms obligate heterodimers with the retinoic acid receptor and acts as a key regulator of biological processes, such as adipocyte differentiation, lipid metabolism, glucose homeostasis and beta-oxidation of fatty acids (PubMed:16150867, PubMed:20829347, PubMed:23525231, PubMed:8702406, PubMed:8706692, PubMed:9065481). Activated by lipid ligands: binds peroxisome proliferators, such as hypolipidemic drugs, and fatty acids, such as prostaglandin J2 metab

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (7)
Regulation of PTEN gene transcriptionTranscriptional regulation of white adipocyte differentiationPPARA activates gene expressionMECP2 regulates transcription factorsNuclear Receptor transcription pathway
EXPRESSÃO TECIDUAL(Ubíquo)
Tecido adiposo
111.2 TPM
Adipose Visceral Omentum
100.8 TPM
Mama
71.3 TPM
Cólon transverso
21.6 TPM
Fibroblastos
20.4 TPM
OUTRAS DOENÇAS (6)
type 2 diabetes mellitusPPARG-related familial partial lipodystrophyinherited obesitygliosarcoma
HGNC:9236UniProt:P37231
CCDC6Coiled-coil domain-containing protein 6Candidate gene tested inAltamente restrito
LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeleton

VIAS BIOLÓGICAS (1)
Signaling by FGFR2 fusions
OUTRAS DOENÇAS (1)
differentiated thyroid carcinoma
HGNC:18782UniProt:Q16204
LPAR4Lysophosphatidic acid receptor 4Candidate gene tested inTolerante
FUNÇÃO

Receptor for lysophosphatidic acid (LPA), a mediator of diverse cellular activities. Transduces a signal by increasing the intracellular calcium ions and by stimulating adenylyl cyclase activity. The rank order of potency for agonists of this receptor is 1-oleoyl- > 1-stearoyl- > 1-palmitoyl- > 1-myristoyl- > 1-alkyl- > 1-alkenyl-LPA

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
G alpha (q) signalling eventsP2Y receptors
EXPRESSÃO TECIDUAL(Baixa expressão)
Ovário
3.0 TPM
Esôfago - Junção
1.2 TPM
Útero
0.9 TPM
Cervix Endocervix
0.8 TPM
Esôfago - Muscular
0.7 TPM
OUTRAS DOENÇAS (1)
differentiated thyroid carcinoma
HGNC:4478UniProt:Q99677
NDUFA13NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13Candidate gene tested inTolerante
FUNÇÃO

Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis (PubMed:27626371). Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone (PubMed:27626371). Involved in the interferon/all-trans-retinoic acid (IFN/RA) induced cell death. This apoptotic activity is inhibited by interaction with viral IRF1. Preve

LOCALIZAÇÃO

Mitochondrion inner membraneNucleus

VIAS BIOLÓGICAS (3)
Respiratory electron transportComplex I biogenesisMitochondrial protein degradation
MECANISMO DE DOENÇA

Hurthle cell thyroid carcinoma

A rare type of thyroid cancer accounting for only about 3-10% of all differentiated thyroid cancers. These neoplasms are considered a variant of follicular carcinoma of the thyroid and are referred to as follicular carcinoma, oxyphilic type.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
261.5 TPM
Coração - Ventrículo esquerdo
190.8 TPM
Coração - Átrio
181.5 TPM
Pituitária
162.4 TPM
Brain Frontal Cortex BA9
149.7 TPM
OUTRAS DOENÇAS (3)
mitochondrial complex I deficiency, nuclear type 28differentiated thyroid carcinomathyroid Hurthle cell carcinoma
HGNC:17194UniProt:Q9P0J0
EIF1AXEukaryotic translation initiation factor 1A, X-chromosomalCandidate gene tested inAltamente restrito
FUNÇÃO

Component of the 43S pre-initiation complex (43S PIC), which binds to the mRNA cap-proximal region, scans mRNA 5'-untranslated region, and locates the initiation codon (PubMed:9732867). This protein enhances formation of the cap-proximal complex (PubMed:9732867). Together with EIF1, facilitates scanning, start codon recognition, promotion of the assembly of 48S complex at the initiation codon (43S PIC becomes 48S PIC after the start codon is reached), and dissociation of aberrant complexes (PubM

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (6)
Translation initiation complex formationRibosomal scanning and start codon recognitionGTP hydrolysis and joining of the 60S ribosomal subunitL13a-mediated translational silencing of Ceruloplasmin expressionFormation of the ternary complex, and subsequently, the 43S complex
EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
82.9 TPM
Ovário
72.0 TPM
Útero
71.4 TPM
Cervix Ectocervix
60.4 TPM
Fallopian Tube
60.4 TPM
OUTRAS DOENÇAS (1)
differentiated thyroid carcinoma
HGNC:3250UniProt:P47813
NTRK1High affinity nerve growth factor receptorCandidate gene tested inTolerante
FUNÇÃO

Receptor tyrosine kinase involved in the development and the maturation of the central and peripheral nervous systems through regulation of proliferation, differentiation and survival of sympathetic and nervous neurons. High affinity receptor for NGF which is its primary ligand (PubMed:1281417, PubMed:15488758, PubMed:17196528, PubMed:1849459, PubMed:1850821, PubMed:22649032, PubMed:27445338, PubMed:8325889). Can also bind and be activated by NTF3/neurotrophin-3. However, NTF3 only supports axon

LOCALIZAÇÃO

Cell membraneEarly endosome membraneLate endosome membraneRecycling endosome membrane

VIAS BIOLÓGICAS (1)
TRKA activation by NGF
MECANISMO DE DOENÇA

Congenital insensitivity to pain with anhidrosis

Characterized by a congenital insensitivity to pain, anhidrosis (absence of sweating), absence of reaction to noxious stimuli, self-mutilating behavior, and intellectual disability. This rare autosomal recessive disorder is also known as congenital sensory neuropathy with anhidrosis or hereditary sensory and autonomic neuropathy type IV or familial dysautonomia type II.

EXPRESSÃO TECIDUAL(Tecido-específico)
Próstata
5.7 TPM
Testículo
4.9 TPM
Cervix Endocervix
4.3 TPM
Útero
3.7 TPM
Fallopian Tube
3.5 TPM
OUTRAS DOENÇAS (4)
hereditary sensory and autonomic neuropathy type 4hereditary sensory and autonomic neuropathy type 5familial medullary thyroid carcinomadifferentiated thyroid carcinoma
HGNC:8031UniProt:P04629
NTRK3NT-3 growth factor receptorCandidate gene tested inAltamente restrito
FUNÇÃO

Receptor tyrosine kinase involved in nervous system and probably heart development. Upon binding of its ligand NTF3/neurotrophin-3, NTRK3 autophosphorylates and activates different signaling pathways, including the phosphatidylinositol 3-kinase/AKT and the MAPK pathways, that control cell survival and differentiation

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (4)
NTF3 activates NTRK3 signalingSignaling by NTRK3 (TRKC)NTRK3 as a dependence receptorReceptor-type tyrosine-protein phosphatases
EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
32.5 TPM
Artéria coronária
22.1 TPM
Aorta
21.6 TPM
Cerebelo
15.8 TPM
Cérebro - Hemisfério cerebelar
13.9 TPM
OUTRAS DOENÇAS (3)
congenital mesoblastic nephromadifferentiated thyroid carcinomafibrosarcoma
HGNC:8033UniProt:Q16288
KRASGTPase KRasCandidate gene tested inAltamente restrito
FUNÇÃO

Ras proteins bind GDP/GTP and possess intrinsic GTPase activity (PubMed:20949621, PubMed:39809765). Plays an important role in the regulation of cell proliferation (PubMed:22711838, PubMed:23698361). Activates MAPK1/MAPK3 resulting in phosphorylation and ultimately degradation of GJA1 (By similarity). Plays a role in promoting oncogenic events by inducing transcriptional silencing of tumor suppressor genes (TSGs) in colorectal cancer (CRC) cells in a ZNF304-dependent manner (PubMed:24623306)

LOCALIZAÇÃO

Cell membraneEndomembrane systemCytoplasm, cytosol

VIAS BIOLÓGICAS (2)
Signaling by moderate kinase activity BRAF mutantsRUNX3 regulates p14-ARF
MECANISMO DE DOENÇA

Leukemia, acute myelogenous

A subtype of acute leukemia, a cancer of the white blood cells. AML is a malignant disease of bone marrow characterized by maturational arrest of hematopoietic precursors at an early stage of development. Clonal expansion of myeloid blasts occurs in bone marrow, blood, and other tissue. Myelogenous leukemias develop from changes in cells that normally produce neutrophils, basophils, eosinophils and monocytes.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
30.7 TPM
Cérebro - Hemisfério cerebelar
25.1 TPM
Esôfago - Muscular
22.2 TPM
Esôfago - Mucosa
21.6 TPM
Esôfago - Junção
20.2 TPM
OUTRAS DOENÇAS (20)
gastric canceracute myeloid leukemialinear nevus sebaceous syndromeNoonan syndrome 3
HGNC:6407UniProt:P01116
PAX8Paired box protein Pax-8Candidate gene tested inAltamente restrito
FUNÇÃO

Transcription factor for the thyroid-specific expression of the genes exclusively expressed in the thyroid cell type, maintaining the functional differentiation of such cells

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
Formation of the nephric ductFormation of intermediate mesoderm
MECANISMO DE DOENÇA

Hypothyroidism, congenital, non-goitrous, 2

A disease characterized by thyroid dysgenesis, the most frequent cause of congenital hypothyroidism, accounting for 85% of case. The thyroid gland can be completely absent (athyreosis), ectopically located and/or severely hypoplastic. Ectopic thyroid gland is the most frequent malformation, with thyroid tissue being found most often at the base of the tongue.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
1192.7 TPM
Rim - Medula
275.9 TPM
Rim - Córtex
170.0 TPM
Fallopian Tube
28.9 TPM
Glândula adrenal
5.5 TPM
OUTRAS DOENÇAS (5)
hypothyroidism, congenital, nongoitrous, 2thyroid hypoplasiaathyreosisdifferentiated thyroid carcinoma
HGNC:8622UniProt:Q06710
NKX2-1Homeobox protein Nkx-2.1Candidate gene tested inAltamente restrito
FUNÇÃO

Transcription factor that binds and activates the promoter of thyroid specific genes such as thyroglobulin, thyroperoxidase, and thyrotropin receptor. Crucial in the maintenance of the thyroid differentiation phenotype. May play a role in lung development and surfactant homeostasis. Forms a regulatory loop with GRHL2 that coordinates lung epithelial cell morphogenesis and differentiation. Activates the transcription of GNRHR and plays a role in enhancing the circadian oscillation of its gene exp

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cellsRegulation of gene expression in beta cells
MECANISMO DE DOENÇA

Chorea, hereditary benign

A rare autosomal dominant movement disorder, defined by early onset in childhood, a stable or non-progressive course of chorea, and no mental deterioration. Chorea is characterized by involuntary, forcible, rapid, jerky movements that may be subtle or become confluent, markedly altering normal patterns of movement.

EXPRESSÃO TECIDUAL(Tecido-específico)
Tireoide
352.6 TPM
Pulmão
89.7 TPM
Hipotálamo
5.6 TPM
Brain Caudate basal ganglia
3.5 TPM
Brain Nucleus accumbens basal ganglia
3.3 TPM
OUTRAS DOENÇAS (6)
brain-lung-thyroid syndromehereditary progressive chorea without dementiaathyreosisdifferentiated thyroid carcinoma
HGNC:11825UniProt:P43699
GAS8-AS1Uncharacterized protein GAS8-AS1Candidate gene tested inDesconhecido
LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
Activation of SMO
OUTRAS DOENÇAS (1)
differentiated thyroid carcinoma
HGNC:1197UniProt:O95177
TPRNucleoprotein TPRCandidate gene tested inAltamente restrito
FUNÇÃO

Component of the nuclear pore complex (NPC), a complex required for the trafficking across the nuclear envelope. Functions as a scaffolding element in the nuclear phase of the NPC essential for normal nucleocytoplasmic transport of proteins and mRNAs, plays a role in the establishment of nuclear-peripheral chromatin compartmentalization in interphase, and in the mitotic spindle checkpoint signaling during mitosis. Involved in the quality control and retention of unspliced mRNAs in the nucleus; i

LOCALIZAÇÃO

NucleusNucleus membraneNucleus envelopeNucleus, nuclear pore complexCytoplasmCytoplasm, cytoskeleton, spindleChromosome, centromere, kinetochore

VIAS BIOLÓGICAS (10)
snRNP AssemblyHCMV Early EventsHCMV Late EventsNEP/NS2 Interacts with the Cellular Export MachineryTransport of Ribonucleoproteins into the Host Nucleus
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
75.9 TPM
Linfócitos
72.8 TPM
Fibroblastos
64.6 TPM
Tireoide
48.7 TPM
Ovário
48.7 TPM
OUTRAS DOENÇAS (3)
intellectual developmental disorder, autosomal recessive 79autosomal recessive non-syndromic intellectual disabilitydifferentiated thyroid carcinoma
HGNC:12017UniProt:P12270
TFGProtein TFGCandidate gene tested inModerado
FUNÇÃO

Plays a role in the normal dynamic function of the endoplasmic reticulum (ER) and its associated microtubules (PubMed:23479643, PubMed:27813252). Required for secretory cargo traffic from the endoplasmic reticulum to the Golgi apparatus (PubMed:21478858)

LOCALIZAÇÃO

Endoplasmic reticulum

VIAS BIOLÓGICAS (1)
COPII-mediated vesicle transport
EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
86.6 TPM
Linfócitos
61.6 TPM
Tireoide
60.1 TPM
Nervo tibial
55.3 TPM
Aorta
53.8 TPM
OUTRAS DOENÇAS (5)
hereditary motor and sensory neuropathy, Okinawa typehereditary spastic paraplegia 57autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutationdifferentiated thyroid carcinoma
HGNC:11758UniProt:Q92734
ESR2Estrogen receptor betaCandidate gene tested inTolerante
FUNÇÃO

Nuclear hormone receptor. Binds estrogens with an affinity similar to that of ESR1/ER-alpha, and activates expression of reporter genes containing estrogen response elements (ERE) in an estrogen-dependent manner (PubMed:20074560) Lacks ligand binding ability and has no or only very low ERE binding activity resulting in the loss of ligand-dependent transactivation ability

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (4)
PI5P, PP2A and IER3 Regulate PI3K/AKT SignalingPIP3 activates AKT signalingConstitutive Signaling by Aberrant PI3K in CancerExtra-nuclear estrogen signaling
MECANISMO DE DOENÇA

Ovarian dysgenesis 8

An autosomal dominant form of ovarian dysgenesis, a disorder characterized by lack of spontaneous pubertal development, primary amenorrhea, uterine hypoplasia, and hypergonadotropic hypogonadism as a result of streak gonads.

EXPRESSÃO TECIDUAL(Baixa expressão)
Ovário
4.6 TPM
Testículo
3.9 TPM
Glândula adrenal
3.6 TPM
Linfócitos
2.3 TPM
Cervix Endocervix
1.4 TPM
OUTRAS DOENÇAS (2)
ovarian dysgenesis 8familial medullary thyroid carcinoma
HGNC:3468UniProt:Q92731
PCM1Pericentriolar material 1 proteinCandidate gene tested inTolerante
FUNÇÃO

Required for centrosome assembly and function (PubMed:12403812, PubMed:15659651, PubMed:16943179). Essential for the correct localization of several centrosomal proteins including CEP250, CETN3, PCNT and NEK2 (PubMed:12403812, PubMed:15659651). Required to anchor microtubules to the centrosome (PubMed:12403812, PubMed:15659651). Also involved in cilium biogenesis by recruiting the BBSome, a ciliary protein complex involved in cilium biogenesis, to the centriolar satellites (PubMed:20551181, PubM

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasmic granuleCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satelliteCytoplasm, cytoskeleton, cilium basal body

VIAS BIOLÓGICAS (7)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
106.3 TPM
Linfócitos
63.2 TPM
Ovário
55.1 TPM
Cérebro - Hemisfério cerebelar
49.3 TPM
Útero
48.2 TPM
OUTRAS DOENÇAS (1)
differentiated thyroid carcinoma
HGNC:8727UniProt:Q15154
ETV6Transcription factor ETV6Candidate gene tested inAltamente restrito
FUNÇÃO

Transcriptional repressor; binds to the DNA sequence 5'-CCGGAAGT-3'. Plays a role in hematopoiesis and malignant transformation

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Signaling by FLT3 fusion proteins
EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
45.0 TPM
Glândula salivar
42.7 TPM
Skin Sun Exposed Lower leg
35.5 TPM
Linfócitos
30.0 TPM
Aorta
29.4 TPM
OUTRAS DOENÇAS (9)
acute myeloid leukemiathrombocytopenia 5B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1)obsolete autosomal thrombocytopenia with normal platelets
HGNC:3495UniProt:P41212
ERC1ELKS/Rab6-interacting/CAST family member 1Candidate gene tested inRestrito
FUNÇÃO

Regulatory subunit of the IKK complex. Probably recruits IkappaBalpha/NFKBIA to the complex. May be involved in the organization of the cytomatrix at the nerve terminals active zone (CAZ) which regulates neurotransmitter release. May be involved in vesicle trafficking at the CAZ. May be involved in Rab-6 regulated endosomes to Golgi transport

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasmMembraneGolgi apparatus membranePresynaptic cell membraneCell projection, podosome

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
34.8 TPM
Cerebelo
32.7 TPM
Artéria tibial
25.6 TPM
Aorta
21.0 TPM
Esôfago - Muscular
20.6 TPM
OUTRAS DOENÇAS (2)
distal monosomy 12pdifferentiated thyroid carcinoma
HGNC:17072UniProt:Q8IUD2
TRIM27Zinc finger protein RFPCandidate gene tested inAltamente restrito
FUNÇÃO

E3 ubiquitin-protein ligase that mediates ubiquitination of various substrates and thereby plays a role in diffent processes including proliferation, innate immunity, apoptosis, immune response or autophagy (PubMed:22829933, PubMed:24144979, PubMed:29688809, PubMed:36111389). Ubiquitinates PIK3C2B and inhibits its activity by mediating the formation of 'Lys-48'-linked polyubiquitin chains; the function inhibits CD4 T-cell activation. Acts as a regulator of retrograde transport: together with MAG

LOCALIZAÇÃO

NucleusCytoplasmNucleus, PML bodyEarly endosomeMitochondrion

VIAS BIOLÓGICAS (2)
Regulation of PTEN stability and activitySuppression of apoptosis
EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
61.2 TPM
Fallopian Tube
55.1 TPM
Baço
54.4 TPM
Cervix Ectocervix
53.1 TPM
Útero
49.7 TPM
OUTRAS DOENÇAS (1)
differentiated thyroid carcinoma
HGNC:9975UniProt:P14373
ALKALK tyrosine kinase receptorCandidate gene tested inRestrito
FUNÇÃO

Neuronal receptor tyrosine kinase that is essentially and transiently expressed in specific regions of the central and peripheral nervous systems and plays an important role in the genesis and differentiation of the nervous system (PubMed:11121404, PubMed:11387242, PubMed:16317043, PubMed:17274988, PubMed:30061385, PubMed:34646012, PubMed:34819673). Also acts as a key thinness protein involved in the resistance to weight gain: in hypothalamic neurons, controls energy expenditure acting as a nega

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Signaling by ALKMDK and PTN in ALK signaling
OUTRAS DOENÇAS (9)
large congenital melanocytic nevusneuroblastomaganglioneuroblastomadifferentiated thyroid carcinoma
HGNC:427UniProt:Q9UM73
TRIM33E3 ubiquitin-protein ligase TRIM33Candidate gene tested inAltamente restrito
FUNÇÃO

Acts as an E3 ubiquitin-protein ligase. Promotes SMAD4 ubiquitination, nuclear exclusion and degradation via the ubiquitin proteasome pathway. According to PubMed:16751102, does not promote a decrease in the level of endogenous SMAD4. May act as a transcriptional repressor. Inhibits the transcriptional response to TGF-beta/BMP signaling cascade. Plays a role in the control of cell proliferation. Its association with SMAD2 and SMAD3 stimulates erythroid differentiation of hematopoietic stem/proge

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
Downregulation of SMAD2/3:SMAD4 transcriptional activityGerm layer formation at gastrulation
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
26.0 TPM
Cérebro - Hemisfério cerebelar
25.6 TPM
Útero
23.2 TPM
Ovário
22.6 TPM
Nervo tibial
21.8 TPM
OUTRAS DOENÇAS (2)
differentiated thyroid carcinomadislocation of the hip-dysmorphism syndrome
HGNC:16290UniProt:Q9UPN9
TERTTelomerase reverse transcriptaseCandidate gene tested inRestrito
FUNÇÃO

Telomerase is a ribonucleoprotein enzyme essential for the replication of chromosome termini in most eukaryotes. Active in progenitor and cancer cells. Inactive, or very low activity, in normal somatic cells. Catalytic component of the teleromerase holoenzyme complex whose main activity is the elongation of telomeres by acting as a reverse transcriptase that adds simple sequence repeats to chromosome ends by copying a template sequence within the RNA component of the enzyme. Catalyzes the RNA-de

LOCALIZAÇÃO

Nucleus, nucleolusNucleus, nucleoplasmNucleusChromosome, telomereCytoplasmNucleus, PML body

VIAS BIOLÓGICAS (3)
Telomere Extension By TelomeraseFormation of the beta-catenin:TCF transactivating complexRegulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence
EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
2.7 TPM
Intestino delgado
0.7 TPM
Brain Caudate basal ganglia
0.6 TPM
Cólon transverso
0.5 TPM
Brain Nucleus accumbens basal ganglia
0.5 TPM
OUTRAS DOENÇAS (13)
dyskeratosis congenita, autosomal dominant 2pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1adrenal cortex carcinomaclear cell sarcoma of kidney
HGNC:11730UniProt:O14746
HABP2Factor VII-activating proteaseCandidate gene tested inTolerante
FUNÇÃO

Cleaves the alpha-chain at multiple sites and the beta-chain between 'Lys-53' and 'Lys-54' but not the gamma-chain of fibrinogen and therefore does not initiate the formation of the fibrin clot and does not cause the fibrinolysis directly (PubMed:11217080). It does not cleave (activate) prothrombin and plasminogen but converts the inactive single chain urinary plasminogen activator (pro-urokinase) to the active two chain form (PubMed:10754382, PubMed:11217080). Activates coagulation factor VII (

LOCALIZAÇÃO

Secreted

MECANISMO DE DOENÇA

Thyroid cancer, non-medullary, 5

A form of non-medullary thyroid cancer (NMTC), a cancer characterized by tumors originating from the thyroid follicular cells. NMTCs represent approximately 95% of all cases of thyroid cancer and are classified into papillary, follicular, Hurthle cell, and anaplastic neoplasms.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
120.6 TPM
Rim - Córtex
8.6 TPM
Pâncreas
6.3 TPM
Rim - Medula
3.6 TPM
Estômago
2.3 TPM
OUTRAS DOENÇAS (3)
familial papillary or follicular thyroid carcinomathrombophilia due to thrombin defectthyroid cancer, nonmedullary, 5
HGNC:4798UniProt:Q14520
MINPP1Multiple inositol polyphosphate phosphatase 1Candidate gene tested inTolerante
FUNÇÃO

Multiple inositol polyphosphate phosphatase that hydrolyzes 1D-myo-inositol 1,3,4,5,6-pentakisphosphate (InsP5[2OH]) and 1D-myo-inositol hexakisphosphate (InsP6) to a range of less phosphorylated inositol phosphates. This regulates the availability of these various small molecule second messengers and metal chelators which control many aspects of cell physiology (PubMed:33257696, PubMed:36589890). Has a weak in vitro activity towards 1D-myo-inositol 1,4,5-trisphosphate which is unlikely to be ph

LOCALIZAÇÃO

Endoplasmic reticulum lumenSecretedCell membrane

VIAS BIOLÓGICAS (1)
Synthesis of IPs in the ER lumen
MECANISMO DE DOENÇA

Thyroid cancer, non-medullary, 2

A form of non-medullary thyroid cancer (NMTC), a cancer characterized by tumors originating from the thyroid follicular cells. NMTCs represent approximately 95% of all cases of thyroid cancer and are classified into papillary, follicular, Hurthle cell, and anaplastic neoplasms.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
34.1 TPM
Glândula adrenal
24.9 TPM
Ovário
14.8 TPM
Linfócitos
14.0 TPM
Pulmão
13.4 TPM
OUTRAS DOENÇAS (4)
pontocerebellar hypoplasia, type 16familial papillary or follicular thyroid carcinomapontocerebellar hypoplasia type 7thyroid cancer, nonmedullary, 2
HGNC:7102UniProt:Q9UNW1
FOXE1Forkhead box protein E1Candidate gene tested inTolerante
FUNÇÃO

Transcription factor that binds consensus sites on a variety of gene promoters and activate their transcription. Involved in proper palate formation, most probably through the expression of MSX1 and TGFB3 genes which are direct targets of this transcription factor. Also implicated in thyroid gland morphogenesis. May indirectly play a role in cell growth and migration through the regulation of WNT5A expression

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Bamforth-Lazarus syndrome

An autosomal recessive disease characterized by congenital hypothyroidism due to thyroid agenesis or thyroid hypoplasia, cleft palate, spiky hair, with or without choanal atresia, and bifid epiglottis.

EXPRESSÃO TECIDUAL(Tecido-específico)
Tireoide
164.5 TPM
Esôfago - Mucosa
8.2 TPM
Vagina
6.1 TPM
Testículo
1.1 TPM
Skin Not Sun Exposed Suprapubic
1.0 TPM
OUTRAS DOENÇAS (5)
Bamforth-Lazarus syndromedifferentiated thyroid carcinomafamilial papillary or follicular thyroid carcinomaathyreosis
HGNC:3806UniProt:O00358
GOLGA5Golgin subfamily A member 5Candidate gene tested inTolerante
FUNÇÃO

Involved in maintaining Golgi structure. Stimulates the formation of Golgi stacks and ribbons. Involved in intra-Golgi retrograde transport

LOCALIZAÇÃO

Golgi apparatus membrane

VIAS BIOLÓGICAS (1)
Intra-Golgi traffic
VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
80.9 TPM
Testículo
55.1 TPM
Artéria tibial
49.1 TPM
Aorta
47.0 TPM
Tecido adiposo
45.9 TPM
OUTRAS DOENÇAS (1)
differentiated thyroid carcinoma
HGNC:4428UniProt:Q8TBA6
DIRC3Candidate gene tested inDesconhecido
LOCALIZAÇÃO

OUTRAS DOENÇAS (2)
differentiated thyroid carcinomahereditary clear cell renal cell carcinoma
HGNC:17805
TRIM24Transcription intermediary factor 1-alphaCandidate gene tested inAltamente restrito
FUNÇÃO

Transcriptional coactivator that interacts with numerous nuclear receptors and coactivators and modulates the transcription of target genes. Interacts with chromatin depending on histone H3 modifications, having the highest affinity for histone H3 that is both unmodified at 'Lys-4' (H3K4me0) and acetylated at 'Lys-23' (H3K23ac). Has E3 protein-ubiquitin ligase activity. During the DNA damage response, participates in an autoregulatory feedback loop with TP53. Early in response to DNA damage, ATM

LOCALIZAÇÃO

NucleusCytoplasmMitochondrion

VIAS BIOLÓGICAS (2)
Signaling by FGFR1 in diseaseSignaling by cytosolic FGFR1 fusion mutants
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
20.9 TPM
Glândula adrenal
19.9 TPM
Ovário
16.5 TPM
Linfócitos
9.1 TPM
Próstata
7.9 TPM
OUTRAS DOENÇAS (1)
differentiated thyroid carcinoma
HGNC:11812UniProt:O15164
RETProto-oncogene tyrosine-protein kinase receptor RetDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation in response to glia cell line-derived growth family factors (GDNF, NRTN, ARTN, PSPN and GDF15) (PubMed:20064382, PubMed:20616503, PubMed:20702524, PubMed:21357690, PubMed:21454698, PubMed:24560924, PubMed:28846097, PubMed:28846099, PubMed:28953886, PubMed:31118272). In contrast to most receptor tyrosine kinases, RET requires not onl

LOCALIZAÇÃO

Cell membraneEndosome membrane

VIAS BIOLÓGICAS (4)
RET signalingFormation of the ureteric budFormation of the nephric ductNPAS4 regulates expression of target genes
MECANISMO DE DOENÇA

Hirschsprung disease 1

A disorder of neural crest development characterized by absence of enteric ganglia along a variable length of the intestine. It is the most common cause of congenital intestinal obstruction. Early symptoms range from complete acute neonatal obstruction, characterized by vomiting, abdominal distention and failure to pass stool, to chronic constipation in the older child.

EXPRESSÃO TECIDUAL(Tecido-específico)
Substância negra
6.3 TPM
Pituitária
4.8 TPM
Cerebelo
4.0 TPM
Cólon sigmoide
4.0 TPM
Brain Frontal Cortex BA9
3.8 TPM
OUTRAS DOENÇAS (12)
multiple endocrine neoplasia type 2Bpheochromocytomafamilial medullary thyroid carcinomamultiple endocrine neoplasia type 2A
HGNC:9967UniProt:P07949
NRASGTPase NRasDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Ras proteins bind GDP/GTP and possess intrinsic GTPase activity

LOCALIZAÇÃO

Cell membraneGolgi apparatus membrane

VIAS BIOLÓGICAS (2)
Signaling by moderate kinase activity BRAF mutantsNeutrophil degranulation
MECANISMO DE DOENÇA

Leukemia, juvenile myelomonocytic

An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
77.3 TPM
Fibroblastos
52.5 TPM
Skin Not Sun Exposed Suprapubic
25.1 TPM
Esôfago - Mucosa
24.4 TPM
Skin Sun Exposed Lower leg
23.4 TPM
OUTRAS DOENÇAS (13)
neurocutaneous melanocytosislarge congenital melanocytic nevusthyroid cancer, nonmedullary, 2colorectal cancer
HGNC:7989UniProt:P01111

Variantes genéticas (ClinVar)

521 variantes patogênicas registradas no ClinVar.

🧬 HRAS: GRCh38/hg38 11p15.5-15.4(chr11:198510-3400939)x3 ()
🧬 HRAS: NM_005343.4(HRAS):c.269T>G (p.Phe90Cys) ()
🧬 HRAS: NM_005343.4(HRAS):c.217_218insCGGCCAGCGCCATGCGGGACCAGTACATGC (p.Met72_Arg73insProAlaSerAlaMetArgAspGlnTyrMet) ()
🧬 HRAS: NM_005343.4(HRAS):c.174_179delinsATCTGGATACAT (p.Ala59_Gly60delinsSerGlyTyrIle) ()
🧬 HRAS: NM_005343.4(HRAS):c.204_218dup (p.Arg73_Thr74insAspGlnTyrMetArg) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

174 vias biológicas associadas aos genes desta condição.

SOS-mediated signalling Activation of RAS in B cells Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants SHC1 events in ERBB2 signaling SHC1 events in ERBB4 signaling Signaling by SCF-KIT Signalling to RAS p38MAPK events GRB2 events in EGFR signaling SHC1 events in EGFR signaling Downstream signal transduction GRB2 events in ERBB2 signaling Tie2 Signaling EGFR Transactivation by Gastrin DAP12 signaling SHC-related events triggered by IGF1R FCERI mediated MAPK activation NCAM signaling for neurite out-growth EPHB-mediated forward signaling Ras activation upon Ca2+ influx through NMDA receptor VEGFR2 mediated cell proliferation CD209 (DC-SIGN) signaling Constitutive Signaling by EGFRvIII SHC-mediated cascade:FGFR1 FRS-mediated FGFR1 signaling SHC-mediated cascade:FGFR2 FRS-mediated FGFR2 signaling SHC-mediated cascade:FGFR3 FRS-mediated FGFR3 signaling FRS-mediated FGFR4 signaling Inactivation of CDC42 and RAC1 RHOA GTPase cycle CDC42 GTPase cycle RAC1 GTPase cycle Spry regulation of FGF signaling Frs2-mediated activation ARMS-mediated activation Signalling to p38 via RIT and RIN RAF activation MAP2K and MAPK activation Negative feedback regulation of MAPK pathway Negative regulation of MAPK pathway Signaling by moderate kinase activity BRAF mutants Signaling by high-kinase activity BRAF mutants Signaling by BRAF and RAF1 fusions Paradoxical activation of RAF signaling by kinase inactive BRAF Signaling downstream of RAS mutants Signaling by RAF1 mutants SHOC2 M1731 mutant abolishes MRAS complex function Gain-of-function MRAS complexes activate RAF signaling Coactivators are recruited to liganded PPARG:RXRA heterodimer PPARA activates gene expression Transcriptional regulation of white adipocyte differentiation Nuclear Receptor transcription pathway SUMOylation of intracellular receptors Regulation of PTEN gene transcription MECP2 regulates transcription factors MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 Signaling by FGFR2 fusions G alpha (q) signalling events P2Y receptors Respiratory electron transport Complex I biogenesis Mitochondrial protein degradation L13a-mediated translational silencing of Ceruloplasmin expression Translation initiation complex formation Formation of a pool of free 40S subunits Formation of the ternary complex, and subsequently, the 43S complex Ribosomal scanning and start codon recognition GTP hydrolysis and joining of the 60S ribosomal subunit PLC-gamma1 signalling Retrograde neurotrophin signalling NGF-independant TRKA activation TRKA activation by NGF PI3K/AKT activation Signalling to STAT3 PIP3 activates AKT signaling Constitutive Signaling by Aberrant PI3K in Cancer Receptor-type tyrosine-protein phosphatases PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling NTF3 activates NTRK3 signaling Signaling by NTRK3 (TRKC) Activated NTRK3 signals through PLCG1 Activated NTRK3 signals through RAS Activated NTRK3 signals through PI3K NTRK3 as a dependence receptor Ca2+ pathway Formation of intermediate mesoderm Formation of the nephric duct Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells Cardiogenesis GAS8 GATA6-AS1 lncRNA p-2S-SMAD2,3:GATA6-AS1 lncRNA:GATA6 gene AS160:IRAP Phospho AS160:14-3-3 p-5S,T642-AS160:IRAP p-5S,T642-AS160:14-3-3:IRAP SMAD2,3 and GATA6-AS1 lncRNA bind the GATA6 gene 14-3-3 binds p-5S,T642-AS160 (TBC1D4) p-AKT1,p-AKT2 phosphorylates AS160 (TBC1D4) CTBP1,CTBP2 binds ZEB1 CD274 mRNA binds miR-142-5p RISC Expression of GATA6 in definitive endoderm CTBP1,CTBP2 binds CDH1 gene promoter SMO translocates to the cilium ISG15 antiviral mechanism Transport of the SLBP independent Mature mRNA Transport of the SLBP Dependant Mature mRNA Transport of Mature mRNA Derived from an Intronless Transcript Transport of Mature mRNA derived from an Intron-Containing Transcript Rev-mediated nuclear export of HIV RNA Transport of Ribonucleoproteins into the Host Nucleus NS1 Mediated Effects on Host Pathways Viral Messenger RNA Synthesis NEP/NS2 Interacts with the Cellular Export Machinery Regulation of Glucokinase by Glucokinase Regulatory Protein Nuclear import of Rev protein Vpr-mediated nuclear import of PICs snRNP Assembly SUMOylation of DNA damage response and repair proteins SUMOylation of ubiquitinylation proteins Nuclear Pore Complex (NPC) Disassembly Regulation of HSF1-mediated heat shock response SUMOylation of SUMOylation proteins SUMOylation of chromatin organization proteins SUMOylation of RNA binding proteins SUMOylation of DNA replication proteins Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) tRNA processing in the nucleus HCMV Early Events HCMV Late Events SARS-CoV-2 activates/modulates innate and adaptive immune responses Signaling by ALK fusions and activated point mutants COPII-mediated vesicle transport ESR-mediated signaling Extra-nuclear estrogen signaling Regulation of PLK1 Activity at G2/M Transition Loss of Nlp from mitotic centrosomes Recruitment of mitotic centrosome proteins and complexes Loss of proteins required for interphase microtubule organization from the centrosome Recruitment of NuMA to mitotic centrosomes Anchoring of the basal body to the plasma membrane AURKA Activation by TPX2 Signaling by membrane-tethered fusions of PDGFRA or PDGFRB Signaling by FLT3 fusion proteins Regulation of PTEN stability and activity Suppression of apoptosis Signaling by ALK ALK mutants bind TKIs ASP-3026-resistant ALK mutants NVP-TAE684-resistant ALK mutants alectinib-resistant ALK mutants brigatinib-resistant ALK mutants ceritinib-resistant ALK mutants crizotinib-resistant ALK mutants lorlatinib-resistant ALK mutants MDK and PTN in ALK signaling Downregulation of SMAD2/3:SMAD4 transcriptional activity Germ layer formation at gastrulation Telomere Extension By Telomerase Formation of the beta-catenin:TCF transactivating complex Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence Synthesis of IPs in the ER lumen TSHR binds TSH/Thyrostimulin Intra-Golgi traffic Signaling by cytosolic FGFR1 fusion mutants Signaling by FGFR1 in disease RAF/MAP kinase cascade RET signaling NPAS4 regulates expression of target genes Formation of the ureteric bud SHC-mediated cascade:FGFR4

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Tumor tireoidiano raro

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
15 papers (10 anos)
#1

Columnar cell variant of papillary thyroid carcinoma in an adolescent: a comprehensive histopathological, immunohistochemical, and molecular analysis.

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie2025

The columnar cell variant (CCV) of papillary thyroid carcinoma (PTC) is a rare histological subtype with distinct morphological and immunohistochemical (IHC) features, which can present diagnostic challenges. We report a case of a 13-year-old girl diagnosed with CCV of PTC (CCV-PTC) following a total thyroidectomy for a solitary thyroid nodule. Histopathological (HP) examination revealed aggressive features, including vascular invasion and extrathyroidal extension. However, no metastases or recurrences were observed during six years of follow-up. This case report provides a comprehensive analysis of a rare CCV-PTC in an adolescent, focusing on its HP, IHC, and molecular characteristics. It also discusses diagnostic pitfalls and differential diagnoses that should be considered.

#2

Spindle epithelial tumor with thymus-like elements (SETTLE): a surgical case diagnosed preoperatively using fine-needle aspiration cytology.

Endocrinology, diabetes &amp; metabolism case reports2025 Apr 01

Spindle epithelial tumor with thymic-like elements (SETTLE) is an extremely rare tumor that occurs primarily in the thyroid gland. Histologically, SETTLE is characterized by the presence of spindle-shaped epithelial cells and glandular structures. However, it is known that diagnosis via fine-needle aspiration cytology can be challenging. SETTLE predominantly occurs in younger individuals and has a less favorable prognosis compared to differentiated thyroid carcinoma. Therefore, ensuring accurate diagnosis and appropriate treatment is crucial. We encountered a case of spindle epithelial tumor with thymus-like differentiation in a 10-year-old patient for whom the preoperative diagnosis was successfully established through fine-needle aspiration cytology, which facilitated appropriate surgical resection. Comprehensive histopathological examination and immunohistochemical analysis are essential to ensure appropriate management and surveillance of SETTLE. A rare thyroid tumor, spindle epithelial tumor with thymic-like elements (SETTLE), was diagnosed preoperatively and treated surgically. SETTLE presents with characteristic histological features that must be recognized for accurate diagnosis. In addition, diagnosis through cytology is often challenging. The primary treatment for SETTLE is surgical intervention as radiotherapy and pharmacological treatments are generally not expected to be highly effective. Radical resection is the only effective treatment, making the selection of the surgical procedure according to the stage of the disease essential.

#3

Sclerosing mucoepidermoid carcinoma of the thyroid with eosinophilia: a case report and review of the literature.

Journal of medical case reports2025 Feb 28

Sclerosing mucoepidermoid carcinoma of the thyroid with eosinophilia (SMECE) is a rare thyroid tumor. More and more reports have proposed that sclerosing mucoepidermoid carcinoma of the thyroid with eosinophilia is significantly invasive, but its origin and pathogenesis are currently controversial. We presented a 42-year-old female of Han ethnicity. She had a 4-year history of thyroid nodules, and mild decrease in thyroid function was observed at the time of surgery. Subsequently, pathological examination revealed typical morphological characteristics of sclerosing mucoepidermoid carcinoma of the thyroid with eosinophilia. Compared with surrounding normal thyroid tissues, significant eosinophil infiltration was observed in the tumor stroma. Negative thyroglobulin immunohistochemical staining and uniquely positive expression of tumor protein p63 and cytokeratin 5/6 were detected in tumor cells. No genetic mutation was detected by next-generation sequencing. No extrathyroid invasion, lymph node metastasis, or distant metastasis was found. The patient was alive without evidence of disease after 24 months of follow-up. The case presentation supported this point that sclerosing mucoepidermoid carcinoma of the thyroid with eosinophilia originated from solid cell nests, and eosinophils might play an important role in the tumorigenesis and development of sclerosing mucoepidermoid carcinoma of the thyroid with eosinophilia. In addition, a comprehensive analysis of the previously reported cases from reported literature revealed that age and distant metastasis might be the risk factors affecting prognosis.

#4

[Intrathyroid thymic carcinoma: report of a case].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery2025 Jan

Objective: Intrathyroid thymic carcinoma(ITTC) is a rare thyroid tumor that lacks typical clinical manifestations and imaging features, making preoperative diagnosis challenging.The primary treatment for ITTC is radical surgery; however, the effectiveness of adjuvant radiotherapy and chemotherapy post-surgery is not well-established. This paper presents a case of ITTC , analyzing the clinical data and correlating it with the literature to explore the clinical manifestations, diagnostic approach, treatment, and prognosis of ITTC. 目的:甲状腺内胸腺癌(intrathyroid thymic carcinoma,ITTC)是一种罕见的甲状腺肿瘤,缺乏典型的临床表现及影像学特征,术前诊断较为困难,根治性手术治疗是其首选的治疗方式,术后是否辅以放化疗,尚无明确结论。本文报道1例ITTC患者,分析该病例临床资料并结合相关文献,探讨ITTC的临床表现、诊疗及预后。.

#5

The coexistence of papillary thyroid carcinoma, anaplastic thyroid carcinoma (squamous cell carcinoma subtype) and poorly differentiated thyroid carcinoma: a case report.

AME case reports2024

Papillary thyroid carcinoma (PTC) accounts for about 60% of adult thyroid carcinoma and generally has an excellent prognosis. Primary squamous cell carcinoma of thyroid (PSCCT) is a rare thyroid tumor with high malignancy and poor prognosis. In 2022, the 5th edition of World Health Organization (WHO) has classified it as a subtype of anaplastic thyroid carcinoma (ATC), abbreviated as ATC-squamous cell carcinoma (SCC) subtype. Poorly differentiated thyroid carcinoma (PDTC) is a kind of follicular-derived malignancy, which is prone to recurrence and distant metastasis. Here, we report a rare case of the coexistence of PTC, ATC-SCC subtype and PDTC. We herein report a case of 69-year-old female who initially presented with a history of left neck mass for one month. Comprehensive auxiliary examinations and postoperative pathology confirmed the diagnosis of PTC combined with ATC-SCC subtype, and PDTC. Total thyroidectomy with radical left cervical lymph node dissection was performed, followed by thyroid-stimulating hormone (TSH) suppressive therapy, 131I, radiotherapy and chemotherapy. The patient showed no tumor recurrence or metastasis after a 5-month postoperative follow-up. The simultaneous occurrence of PTC, ATC-SCC subtype, and PDTC is extremely rare in clinical terms or literature reports. The treatment has not been standardized, and early radical surgery is the first choice. In addition, the combination of adjuvant therapies such as TSH suppressive therapy, radiotherapy, chemotherapy and 131I may further improve the prognosis of the patient.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC1 artigos no totalmostrando 15

2025

Columnar cell variant of papillary thyroid carcinoma in an adolescent: a comprehensive histopathological, immunohistochemical, and molecular analysis.

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
2025

Spindle epithelial tumor with thymus-like elements (SETTLE): a surgical case diagnosed preoperatively using fine-needle aspiration cytology.

Endocrinology, diabetes &amp; metabolism case reports
2025

Sclerosing mucoepidermoid carcinoma of the thyroid with eosinophilia: a case report and review of the literature.

Journal of medical case reports
2025

[Intrathyroid thymic carcinoma: report of a case].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery
2024

The coexistence of papillary thyroid carcinoma, anaplastic thyroid carcinoma (squamous cell carcinoma subtype) and poorly differentiated thyroid carcinoma: a case report.

AME case reports
2024

Cytomorphological traits of fine-needle aspirates of hyalinizing trabecular tumor of the thyroid gland: A brief report.

Indian journal of pathology &amp; microbiology
2023

Case report: Thymoid differentiated carcinoma of thyroid: Two cases.

Frontiers in surgery
2023

Type 2 deiodinase is expressed in anaplastic thyroid carcinoma and its inhibition causes cell senescence.

Endocrine-related cancer
2021

Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis.

Endocrine-related cancer
2020

Parathyroid carcinoma with sarcomatoid differentiation: a case report and literature review.

Diagnostic pathology
2020

Medullary thyroid carcinoma combined with papillary thyroid carcinoma: case report and literature review.

International journal of clinical and experimental pathology
2020

SRY‑related HMG box‑2 role in anaplastic thyroid cancer aggressiveness is related to the fibronectin 1 and PI3K/AKT pathway.

Molecular medicine reports
2019

Typical manifestations of Hürthle cell adenoma of the thyroid on contrast-enhanced CT: A case report.

Medicine
2019

Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.

Annales d'endocrinologie
2018

Hyalinizing Trabecular Tumor of the Thyroid Gland, a Diagnostic Challenge in Fine-Needle Aspiration Cytology: Case Report.

Journal of pathology and translational medicine

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Tumor tireoidiano raro.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Tumor tireoidiano raro

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Columnar cell variant of papillary thyroid carcinoma in an adolescent: a comprehensive histopathological, immunohistochemical, and molecular analysis.
    Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie· 2025· PMID 41382956mais citado
  2. Spindle epithelial tumor with thymus-like elements (SETTLE): a surgical case diagnosed preoperatively using fine-needle aspiration cytology.
    Endocrinology, diabetes &amp; metabolism case reports· 2025· PMID 40366248mais citado
  3. Sclerosing mucoepidermoid carcinoma of the thyroid with eosinophilia: a case report and review of the literature.
    Journal of medical case reports· 2025· PMID 40022195mais citado
  4. [Intrathyroid thymic carcinoma: report of a case].
    Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery· 2025· PMID 39734180mais citado
  5. The coexistence of papillary thyroid carcinoma, anaplastic thyroid carcinoma (squamous cell carcinoma subtype) and poorly differentiated thyroid carcinoma: a case report.
    AME case reports· 2024· PMID 38711906mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:100087(Orphanet)
  2. MONDO:0015074(MONDO)
  3. GARD:19762(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)
  7. Q826522(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Tumor tireoidiano raro
Compêndio · Raras BR

Tumor tireoidiano raro

ORPHA:100087 · MONDO:0015074
Prevalência
1-9 / 100 000
Prevalência
3.2 (Worldwide)
UMLS
C0040136
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades